BMS-309403 sodium - ≥99% , CAS No.2802523-05-1

CAS: 2802523-05-1 Cat. No.: B649312 Formula: C31H25N2NaO3 Peso molecolare: 496.53
Disponibile su ordine
QUALITÀ & PUREZZA ≥99%
Storage
Store at 2-8°C,Desiccated
Shipped In
Wet ice
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5mg
B649312-5mg
Su ordinazione · 8–12 settimane
96,23€
10mg
B649312-10mg
Su ordinazione · 8–12 settimane
174,33€
25mg
B649312-25mg
Su ordinazione · 8–12 settimane
347,88€
50mg
B649312-50mg
Su ordinazione · 8–12 settimane
556,13€
100mg
B649312-100mg
Su ordinazione · 8–12 settimane
885,87€
Enter a quantity for the sizes you want to add.

Panoramica

BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with K i s of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

In Vitro

Treatment with BMS-309403 significantly decreased MCP-1 production from THP-1 macrophages in a dose- and time-dependent manner. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

BMS-309403 sodium (15 mg/kg; chronic treatment; daily for 6 weeks) improves endothelial function, phosphorylated and total eNOS and reduced plasma triglyceride levels but did not affect endothelium-independent relaxations. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: C57BL/6J mice (ApoE −/− mice)Dosage: 15 mg/kg Administration: Chronic treatment ; daily for 6 weeks Result: Significantly increased the phosphorylated eNOS (Ser1177) and total eNOS but not the phosphorylated to total eNOS ratio in aortae of 18 weeks old ApoE −/− mice.

Form:Solid

Specifiche

Specifiche e purezza
≥99%
Meccanismi biochimici e fisiologici
BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with K i s of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-
Condizioni di conservazione di stoccaggio
Store at 2-8°C,Desiccated
Spedito in
Wet ice
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Purezza
≥99%
Nomi e identificatori
Peso molecolare
496.53

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
SolubilitàH2O : 100 mg/mL (201.40 mM; Need ultrasonic) DMSO : 50 mg/mL (100.70 mM; Need ultrasonic)
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Domande frequenti

How is this product shipped?
This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.